Literature DB >> 35767183

Impact of VEGFA promoter polymorphisms on esophageal cancer risk in North-West Indians: a case-control study.

Kamlesh Guleria1, Simranjot Kaur2, Deepanshi Mahajan2, Vasudha Sambyal2, Meena Sudan3, Manjit Singh Uppal4.   

Abstract

BACKGROUND: Angiogenesis play a critical role in the development and progression of tumors in solid tumors. Vascular endothelial growth factor (VEGF) is one of the most important endothelial cell mitogen which plays a critical role in normal physiological and tumor angiogenesis.
OBJECTIVES: The objective of this case-control study was to investigate the association of VEGF-2578C/A, -2549 I/D, and -460T/C promoter polymorphisms with esophageal cancer risk in North-West Indians.
METHODS: In this study, 200 sporadic esophageal cancer patients and 200 healthy, unrelated, age and gender matched controls were analyzed. The genomic DNA was extracted from blood samples using phenol chloroform method. Genotyping of VEGF- 2549I/D polymorphism was carried out by direct polymerase chain reaction (PCR) whereas VEGF -2578C/A and VEGF-460T/C) polymorphisms were analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method.
RESULTS: AA genotype (p = 0.005) and A allele (p = 0.005) VEGF -2578 C/A, II genotype (p = 0.011) and I allele (p = 0.012) of VEGF - 2549 I/D and CC genotype (p = 0.013) and C allele of VEGF-460T/C polymorphisms were significantly associated with increased risk of esophageal cancer. Stratification of data on the basis of gender showed that VEGF -2578 AA genotype (p = 0.001) and A allele (p = 0.001); VEGF -2549 II genotype (p = 0.002) and I allele (p = 0.002) and VEGF- 460CC genotype (p = 0.001) and C allele (p = 0.002) was significantly associated with increased risk of esophageal cancer in female group. Haplotype analysis revealed that A-2578 I- 2549 C- 460 haplotype was significantly associated with increased risk for esophageal cancer in total samples (p = 0.008) as well as in female group (p = 0.001).
CONCLUSIONS: The results of present study indicate that VEGF -2578C/A, - 2549I/D and -460T/C polymorphisms were significantly associated with increased risk of esophageal cancer in North-West Indians.
© 2022. The Author(s) under exclusive licence to The Genetics Society of Korea.

Entities:  

Keywords:  Angiogenesis; Esophageal cancer; Polymorphism; VEGF

Mesh:

Substances:

Year:  2022        PMID: 35767183     DOI: 10.1007/s13258-022-01269-2

Source DB:  PubMed          Journal:  Genes Genomics        ISSN: 1976-9571            Impact factor:   2.164


  86 in total

1.  VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression.

Authors:  Ying Cao; Guangqi E; Enfeng Wang; Krishnendu Pal; Shamit K Dutta; Dafna Bar-Sagi; Debabrata Mukhopadhyay
Journal:  Cancer Res       Date:  2012-06-12       Impact factor: 12.701

2.  VEGF polymorphisms may be associated with susceptibility to colorectal cancer: a case-control study.

Authors:  Anna G Antonacopoulou; Anastasia E Kottorou; Fotinos-Ioannis D Dimitrakopoulos; Vasiliki Triantafyllia; Stella Marousi; Angelos Koutras; Haralabos P Kalofonos
Journal:  Cancer Biomark       Date:  2011       Impact factor: 4.388

3.  The association of VEGF rs833061 and rs2010963 polymorphisms with susceptibility to colorectal cancer in an Iranian population.

Authors:  Ehsan Bakhshian-Dehkordi; Mohsen Safaei; Soheila Fattahi; Mostafa Faghani; Fatemeh Deris; Morteza Hashemzadeh Chaleshtori
Journal:  Cancer Epidemiol       Date:  2021-09-27       Impact factor: 2.984

4.  Estimation of vascular endothelial growth factor gene -460 C/T polymorphism as a biomarker in oral squamous cell carcinoma patients from the Indian subcontinent.

Authors:  Archana P Borase; Sindhu M Ganvir; Vinay K Hazarey; Suchitra R Gosavi; Anand A Mohatta; Jasmine Singh
Journal:  J Investig Clin Dent       Date:  2014-07-22

5.  Vascular endothelial growth factor polymorphisms -1154 G/A and -460 C/T are not associated with VEGF mRNA expression and susceptibility to sporadic colon cancer.

Authors:  Tamara Cacev; Bozo Loncar; Sven Seiwerth; Sime Spaventi; Sanja Kapitanovic
Journal:  DNA Cell Biol       Date:  2008-10       Impact factor: 3.311

6.  Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.

Authors:  Mansour S Al-Moundhri; Maryam Al-Nabhani; Ikram A Burney; Abdul-Aziz Al-Farsi; Bassim Al-Bahrani
Journal:  Mol Carcinog       Date:  2009-12       Impact factor: 4.784

7.  Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis.

Authors:  Penelope A Bradbury; Rihong Zhai; Clement Ma; Wei Xu; Jessica Hopkins; Matthew J Kulke; Kofi Asomaning; Zhaoxi Wang; Li Su; Rebecca S Heist; Thomas J Lynch; John C Wain; David Christiani; Geoffrey Liu
Journal:  Clin Cancer Res       Date:  2009-07-07       Impact factor: 12.531

8.  Role of pesticides in the induction of tumor angiogenesis.

Authors:  Salimath P Bharathi; Harsh M Raj; Smita Jain; Basu Dev Banerjee; Tanzeel Ahmed; Vinod Kumar Arora
Journal:  Anticancer Res       Date:  2013-01       Impact factor: 2.480

9.  Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription.

Authors:  G Akiri; D Nahari; Y Finkelstein; S Y Le; O Elroy-Stein; B Z Levi
Journal:  Oncogene       Date:  1998-07-16       Impact factor: 9.867

10.  Rapid purification of human DNA from whole blood for potential application in clinical chemistry laboratories.

Authors:  K Adeli; G Ogbonna
Journal:  Clin Chem       Date:  1990-02       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.